NewsBenzingaRoche lance le test mondial VENTANA BAP1 (SP527) pour distinguer le mésothéliome malin des cancers du poumon, du sein et de l’estomac, élargissant ainsi son portefeuille de diagnostics oncologiques Roche lance le test mondial VENTANA BAP1 (SP527) pour distinguer le mésothéliome malin des cancers du poumon, du sein et de l’estomac, élargissant ainsi son portefeuille de diagnostics oncologiques Benzinga 2026.10.28 06:26 (GMT+0) Open on Benzinga Other news Motorola Solutions Hikes Quarterly Dividend From $1.21 To $1.34 Per Share These 9 Congress Members Could Have Increased Interest in Nvidia’s Q3 Earnings as 2026 Shareholders $100 Invested In Cigna Group 20 Years Ago Would Be Worth This Much Today Needham Maintains Buy on FuboTV, Lowers Price Target to $10 BTIG Reiterates Buy on Amer Sports, Maintains $42 Price Target If You Invested $1000 In Ulta Beauty Stock 15 Years Ago, You Would Have This Much Today